Menu
← Oncology Approval Tracker
FDA DECISION ·
Yervoy
ipilimumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Changes the adjuvant melanoma regimen after complete resection in the labeled population from 10 mg/kg to 3 mg/kg and shortens the IV infusion from 90 to 30 minutes.
LAMPGEN ANALYSIS
Why it matters
FDA approved a lower dose and shorter infusion in the existing adjuvant melanoma setting.
What research teams should watch
Retire obsolete order sets and check the indication-specific weight-based dose when reconciling older protocols.
PRIMARY RECORDS